Rheumatology 2050: How our specialty is changing
Mariam Omar, Katie Bechman, Mark Russell, James Galloway · 2025
Read Rheumatology 2050: How our specialty is changing by Mariam Omar, Katie Bechman, Mark Russell, James Galloway (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12861654.txt.
Description
Mariam Omar, Katie Bechman, Mark Russell, and James Galloway sketch rheumatology as it may stand in twenty fifty. The field has swung in one generation from broad immune suppression to drugs that strike single pathways. The next swing, they argue, will sort patients by molecule before it picks the drug.
Their 2025 review tours the forces at work. Gene finds name whole new diseases, and cell therapies have cleared severe lupus in early use. Other shots aim to head off autoimmunity before it sets. Serology, genomics, and joint tissue typing fuse into one patient map. Costs and fairness get their own hard look, since wonder drugs serve no one if no system can pay.
Catalog record
| CREATOR | Mariam Omar, Katie Bechman, Mark Russell, James Galloway |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |